Researchers are investigating whether a common cholesterol drug could be repurposed to treat HPV-positive cervical cancer.
We are thrilled to share that the first trial site has been initiated and activation of additional clinical sites continues,” said Frank Bedu-Addo, PhD, President and Chief Executive Officer of PDS ...
Researchers from the University of Chicago Medicine Comprehensive Cancer Center have demonstrated the potential of a novel ...
Many Americans remain unaware of the cancer risk for both men and women posed by human papillomavirus, a new Ohio State ...
Despite their frequency, head and neck cancers often evade early detection, presenting silently until they reach advanced ...
Many Americans remain unaware of the cancer risk for both men and women posed by human papillomavirus (HPV), a new Ohio State ...
Many Americans remain unaware of the cancer risk for both men and women posed by human papillomavirus (HPV), a new Oh ...
Katharine Price, M.D., Associate Professor of Oncology, Head and Neck Disease Group ... “We are optimistic about the potential of Versamune ® HPV in combination with pembrolizumab to enhance ...
A new government report says that rates for precancerous lesions decreased about 80% among younger women who were screened ...
A new survey released today by The Ohio State University Comprehensive Cancer Center highlights significant misconceptions ...
Researchers from the University of Chicago Medicine Comprehensive Cancer Center demonstrated the potential of a novel treatment approach including immunotherapy to treat advanced human papillomavirus ...
In very rare cases, oral HPV causes oropharyngeal cancer—a kind of head and neck cancer that affects the middle part of the throat, known as the oropharynx. In most cases, oral human papillomavirus ...